BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology Today - ECPv6.16.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncologynewstoday.co.uk
X-WR-CALDESC:Events for Oncology Today
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251203T090000
DTEND;TZID=Europe/London:20251203T170000
DTSTAMP:20251027T135951Z
CREATED:20251027T135951Z
LAST-MODIFIED:20251027T135951Z
UID:8045-1764752400-1764781200@oncologynewstoday.co.uk
SUMMARY:A User Guide to Cancer Immunotherapy Conference
DESCRIPTION:Following successful meetings from 2016 to 2024\, we are delighted to continue this face-to-face meeting for our User Guide to Cancer Immunotherapy Conference in December 2025. Our updated programme will provide an overview of immunotherapy\, with a focus on the recognition and management of immune-mediated toxicities. The meeting will have a strong clinical emphasis\, aimed at providing delegates with practical guidance that can be used in daily practice. As such\, it will be of value to healthcare professionals involved in the delivery of cancer care including doctors\, nurses\, pharmacists and physician associates working in oncology\, acute medicine\, emergency medicine\, medical specialties and general practice. We look forward to seeing you in December 2025.
URL:https://oncologynewstoday.co.uk/event/a-user-guide-to-cancer-immunotherapy-conference-2/
LOCATION:The Royal Marsden Education and Conference Centre\, Chelsea\, Stewart's Grove\, London\, SW3 6JJ\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251204T090000
DTEND;TZID=Europe/London:20251204T170000
DTSTAMP:20251027T134944Z
CREATED:20251027T134904Z
LAST-MODIFIED:20251027T134944Z
UID:8043-1764838800-1764867600@oncologynewstoday.co.uk
SUMMARY:Bladder Oncology Study Day
DESCRIPTION:Overview \nThis multidisciplinary educational event brings together renowned experts and healthcare professionals to explore the rapidly evolving landscape of bladder cancer management. As one of the most common urological malignancies\, bladder cancer presents unique challenges requiring coordinated care across multiple specialties. Our study day addresses critical developments in molecular diagnostics\, emerging therapeutic approaches\, and patient-centred care strategies that are transforming outcomes for patients \nWhat to expect \n\nApply current evidence-based approaches to bladder cancer management\nIntegrate new diagnostic and therapeutic strategies into clinical practice\nEnhance multidisciplinary team collaboration\nImprove patient counselling and shared decision-making\n\nAgenda \nTo be confirmed \nPlease note: one livestream ticket purchase is equivalent to one CPD certificate and the name on the ticket will match the one on the booking registration. Where the ‘5 for 4’ ticket option is purchased\, we will contact you directly to ask for the 5 names for the certificates. Further details can be found in our T&C’s further down this page. \nVenue Information \nThe Christie Education Centre is located on the 2nd floor in Dept 17 of the main hospital and can be accessed by stairs or lift. Toilets are also on this floor including an accessible toilet. The auditorium has a hearing loop available and ramp access. A prayer room is available and close by. We want everyone attending our event in person to have the best possible experience. We provide regular breaks\, access to quiet spaces etc\, but If there is anything else we can do to make the day/your experience more comfortable\, please let us know by either completing this form\, Inclusive learning support or emailing us: the-christie.learner.support@nhs.net \nPlease see our booking Terms and Conditions here \nClick here to read our privacy policy: http://www.christie.nhs.uk/professionals/education/continuing-professional-development/study-days-and-conferences/school-of-oncology-events-privacy-policy/ \nThis event may be subject to change from Hybrid to fully virtual. Correspondence in regards to any changes in the delivery of this event will be notified directly by The Christie Insttute for Cancer Education. \nEmail the-christie.educationevents@nhs.net or call +44 (0) 161 918 7409
URL:https://oncologynewstoday.co.uk/event/bladder-oncology-study-day/
LOCATION:The Christie School of Oncology\, 550 Wilmslow Road\, Manchester\, M20 4BX\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251204T090000
DTEND;TZID=Europe/London:20251204T170000
DTSTAMP:20251114T104408Z
CREATED:20251114T104408Z
LAST-MODIFIED:20251114T104408Z
UID:8104-1764838800-1764867600@oncologynewstoday.co.uk
SUMMARY:Bladder Oncology Study Day
DESCRIPTION:Overview \nThis multidisciplinary educational event brings together renowned experts and healthcare professionals to explore the rapidly evolving landscape of bladder cancer management. As one of the most common urological malignancies\, bladder cancer presents unique challenges requiring coordinated care across multiple specialties. Our study day addresses critical developments in molecular diagnostics\, emerging therapeutic approaches\, and patient-centred care strategies that are transforming outcomes for patients \nWhat to expect \n\nApply current evidence-based approaches to bladder cancer management\nIntegrate new diagnostic and therapeutic strategies into clinical practice\nEnhance multidisciplinary team collaboration\nImprove patient counselling and shared decision-making\n\n  \nJoin Your Colleagues: \n\nIn-person: Education Centre\, The Christie (easy access via local transport links)\nVirtual: Participate from your workplace\nCatch-up access: 6-month replay available – perfect for busy clinical schedules\n\nONCOLOGYNT – For 10% off
URL:https://oncologynewstoday.co.uk/event/bladder-oncology-study-day-2/
LOCATION:The Christie School of Oncology\, 550 Wilmslow Road\, Manchester\, M20 4BX\, United Kingdom
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251209T200000
DTEND;TZID=Europe/London:20251209T210000
DTSTAMP:20251126T153515Z
CREATED:20251126T153515Z
LAST-MODIFIED:20251126T153515Z
UID:8168-1765310400-1765314000@oncologynewstoday.co.uk
SUMMARY:BAHNOhow? Session 3: Mental Health in Head & Neck Cancer – The MDT Role
DESCRIPTION:This third session in the BAHNO MDT Interface Series focuses on the challenge of mental health in Head & Neck Cancer. It will explore how members of the MDT can recognise\, discuss\, and respond to mental health concerns in their patients. \nKey Topics \n• The relationship between mental health and head & neck cancer – prevalence\, impact on outcomes\, and vice versa \n• Role of Clinical Psychology \n• How to ask about and acknowledge mental health issues in clinic \n• Responding to risk: what to do if a patient mentions suicidal thoughts \n• Signposting\, escalation\, and practical MDT strategies \n• Panel discussion and live Q&A \nSpeakers \nElspeth Desert – Consultant Clinical Psychologist \nJane Anderson – Senior lecturer in Advaned Clinical Practice (Mental Health) \nWho Should Attend: All members of the Head & Neck Cancer MDT who want to build confidence in recognising and addressing mental health challenges.
URL:https://oncologynewstoday.co.uk/event/bahnohow-session-3-mental-health-in-head-neck-cancer-the-mdt-role/
LOCATION:Online
CATEGORIES:Oncology Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251210T080000
DTEND;TZID=Europe/London:20251212T170000
DTSTAMP:20251027T152433Z
CREATED:20251027T152433Z
LAST-MODIFIED:20251027T152433Z
UID:8047-1765353600-1765558800@oncologynewstoday.co.uk
SUMMARY:ESMO Immuno-Oncology Congress 2025
DESCRIPTION:Save the date for the ESMO Immuno-Oncology Congress 2025\, taking place from 10 until 12 December 2025 as an onsite event in London\, UK\, as well as online.\n\n\n\n\nThis international event provides valuable knowledge: from basic science to translational research and clinical development\, cutting-edge science\, and excellent networking opportunities. \nTake part in this meeting to learn\, share your research and expertise and connect with the stakeholders that are making a difference in the field. \n\n\n\n\n\n\nLearning objectives\n\nAccess immersion sessions in immunobiology and immuno-oncology translational research insights\nReview state of the art\, checkpoint inhibitor-based therapeutic strategies in immuno-oncology\nUnderstand recent developments in immune modulation\, including tumour microenvironment\, immunometabolism\, epigenetics and cell signalling\nConnect with Industry and independent investigators for an overview of  research and development in immuno-oncology\, including cellular therapies\, vaccines and immune modulators\, intratumoural immunotherapy and multispecific constructs
URL:https://oncologynewstoday.co.uk/event/esmo-immuno-oncology-congress-2025/
LOCATION:Queen Elizabeth II Centre\, QEII Centre\, London\, SW1P 3EE
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251212T090000
DTEND;TZID=Europe/London:20251212T170000
DTSTAMP:20251126T154218Z
CREATED:20251126T154218Z
LAST-MODIFIED:20251126T154218Z
UID:8171-1765530000-1765558800@oncologynewstoday.co.uk
SUMMARY:BIR/HLH Lung cancer screening study day 2025
DESCRIPTION:HLH ccEvent Overview \n\n\nDate: 12 December 2025 \nTime: 9am – 5pm \nVenue: America Square\, Cavendish Venues \nCPD: 6 credits \nA one-day in-person study day hosted by The HLH Imaging Group (HLH) focusing on the end-to-end process for lung cancer screening (LCS) in the UK. This programme brings together shared multidisciplinary learning from NHS Lung Cancer Screening (LCS) sites as well as offering insights on the potential rollout of a national lung cancer screening programme. \nWho should attend? \nThe event is open to all multidisciplinary TLHC/lung cancer pathway stakeholders including: clinical radiologists who report on LCS; respiratory physicians; TLHC programme managers and Cancer Alliance Leads radiology trainees; CT radiographers; TLHC nurses; thoracic pathologist and thoracic surgeons.
URL:https://oncologynewstoday.co.uk/event/bir-hlh-lung-cancer-screening-study-day-2025/
LOCATION:America Square\, Cavendish Venues\, United Kingdom
CATEGORIES:Oncology Events
END:VEVENT
END:VCALENDAR